AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45

Authors: Andreoletti, L Lescieux, A Lambert, V Si-Mohamed, A Matta, M Wattre, P Belec, L
Citation: L. Andreoletti et al., Semiquantitative detection of JCV-DNA in peripheral blood leukocytes from HIV-1-Infected patients with or without Progressive Multifocal Leukoencephalopathy, J MED VIROL, 66(1), 2002, pp. 1-7

Authors: Carreno, MP Chomont, N Kazatchkine, MD Irinopoulou, T Krief, C Mohamed, AS Andreoletti, L Matta, M Belec, L
Citation: Mp. Carreno et al., Binding of LFA-1 (CD11a) to intercellular adhesion molecule 3 (ICAM-3; CD50) and ICAM-2 (CD102) triggers transmigration of human immunodeficiency virus type 1-infected monocytes through mucosal epithelial cells, J VIROLOGY, 76(1), 2002, pp. 32-40

Authors: Belec, L Maletinska, L Slaninova, J Lubell, WD
Citation: L. Belec et al., The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs, J PEPT RES, 58(3), 2001, pp. 263-273

Authors: Chomont, N Gresenguet, G Levy, M Hocini, H Becquart, P Matta, M Tranchot-Diallo, J Andreoletti, L Carreno, MP Kazatchkine, MD Belec, L
Citation: N. Chomont et al., Detection of Y chromosome DNA as evidence of semen in cervicovaginal secretions of sexually active women, CL DIAG LAB, 8(5), 2001, pp. 955-958

Authors: Chomont, N Gresenguet, G Hocini, H Becquart, P Matta, M Andreoletti, L Si-Mohamed, A Carreno, MP Kazatchkine, M Belec, L
Citation: N. Chomont et al., Polymerase chain reaction for Y chromosome to detect semen in cervicovaginal fluid: a prerequisite to assess HIV-specific vaginal immunity and HIV genital shedding, AIDS, 15(6), 2001, pp. 801-802

Authors: Landau, A Batisse, D Piketty, C Van Huyen, LPD Bloch, F Belec, L Bruneval, P Weiss, L Jian, R Kazatchkine, MD
Citation: A. Landau et al., Long-term efficacy of combination therapy with interferon-alpha 2b and ribavirin for severe chronic hepatitis C in HIV-infected patients, AIDS, 15(16), 2001, pp. 2149-2155

Authors: Si-Mohamed, A Andreoletti, L Colombet, I Carreno, MP Lopez, G Chatelier, G Kazatchkine, MD Belec, L
Citation: A. Si-mohamed et al., Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: Comparison of reverse transcription-PCR amplification (AMPLICOR HIV-1 MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0), J CLIN MICR, 39(6), 2001, pp. 2055-2059

Authors: Halab, L Belec, L Lubell, WD
Citation: L. Halab et al., Improved synthesis of (2S,5S)-5-tert-butylproline, TETRAHEDRON, 57(30), 2001, pp. 6439-6446

Authors: Hocini, H Becquart, P Bouhlal, H Chomont, N Ancuta, P Kazatchkine, MD Belec, L
Citation: H. Hocini et al., Active and selective transcytosis of cell-free human immunodeficiency virus through a tight polarized monolayer of human endometrial cells, J VIROLOGY, 75(11), 2001, pp. 5370-5374

Authors: Belec, L Ghys, PD Hocini, H Nkengasong, JN Tranchot-Diallo, J Diallo, MO Ettiegne-Traore, V Maurice, C Becquart, P Matta, M Si-Mohamed, A Chomont, N Coulibaly, IM Wiktor, SZ Kazatchkine, MD
Citation: L. Belec et al., Cervicovaginal secretory antibodies to human immunodeficiency virus type 1(HIV-1) that block viral transcytosis through tight epithelial barriers inhighly exposed HIV-1-seronegative African women, J INFEC DIS, 184(11), 2001, pp. 1412-1422

Authors: Piketty, C Weiss, L Thomas, F Mohamed, AS Belec, L Kazatchkine, MD
Citation: C. Piketty et al., Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen, J INFEC DIS, 183(9), 2001, pp. 1328-1335

Authors: Gherardi, RK Coquet, M Cherin, P Belec, L Moretto, P Dreyfus, PA Pellissier, JF Chariot, P Authier, FJ
Citation: Rk. Gherardi et al., Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle, BRAIN, 124, 2001, pp. 1821-1831

Authors: Kazatchkine, MD Van, PN Costagliola, D Mohammed, AS Ledeine, JM Troccaz, M Belec, L
Citation: Md. Kazatchkine et al., Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy, J ACQ IMM D, 24(5), 2000, pp. 418-424

Authors: Tevi-Benissan, C Makuva, M Morelli, A Georges-Courbot, MC Matta, M Georges, A Belec, L
Citation: C. Tevi-benissan et al., Protection of cynomolgus macaque against cervicovaginal transmission of SIVmac251 by the spermicide benzalkonium chloride, J ACQ IMM D, 24(2), 2000, pp. 147-153

Authors: Darras-Joly, C Belec, L Lortholary, O
Citation: C. Darras-joly et al., Subacute polyradiculoneuritis revealing syphilis in an HIV negative man, CL MICRO IN, 6(5), 2000, pp. 284-285

Authors: Belec, L Gresenguet, G Keou, FXM Mayaud, P
Citation: L. Belec et al., High frequency of asymptomatic shedding of herpes simplex virus type 2 in African women, CL MICRO IN, 6(1), 2000, pp. 56-57

Authors: Hocini, H Becquart, P Bouhlal, H Adle-Biassette, H Kazatchkine, MD Belec, L
Citation: H. Hocini et al., Secretory leukocyte protease inhibitor inhibits infection of monocytes andlymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers, CL DIAG LAB, 7(3), 2000, pp. 515-518

Authors: Lozinguez, O Arnaud, E Belec, L Nicaud, V Alhenc-Gelas, M Fiessinger, JN Aiach, M Emmerich, J
Citation: O. Lozinguez et al., Demonstration of an association between Chlamydia pneumoniae infection andvenous thromboembolic disease, THROMB HAEM, 83(6), 2000, pp. 887-891

Authors: Belec, L Tevi-Benissan, C Bianchi, A Cotigny, S Beumont-Mauviel, M Si-Mohamed, A Malkin, JE
Citation: L. Belec et al., In vitro inactivation of Chlamydia trachomatis and of a panel of DNA (HSV-2, CMV, adenovirus, BK virus) and RNA (RSV, enterovirus) viruses by the spermicide benzalkonium chloride, J ANTIMICRO, 46(5), 2000, pp. 685-693

Authors: Landau, A Batisse, D Van Huyen, JPD Piketty, C Bloch, F Pialoux, G Belec, L Petite, JP Weiss, L Kazatchkine, M
Citation: A. Landau et al., Efficacy and safety of combination therapy with interferon-alpha 2b and ribavirin for chronic hepatitis C in HIV-infected patients, AIDS, 14(7), 2000, pp. 839-844

Authors: Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD
Citation: C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628

Authors: Ghys, PD Belec, L Diallo, MO Ettiegne-Traore, V Becquart, P Maurice, C Nkengasong, JN Coulibaly, IM Greenberg, AE Laga, M Wiktor, SZ
Citation: Pd. Ghys et al., Cervicovaginal anti-HIV antibodies in HIV-seronegative female sex workers in Abidjan, Cote d'Ivoire, AIDS, 14(16), 2000, pp. 2603-2608

Authors: Sharshar, T Auriant, I Dorandeu, A Saghatchian, M Belec, L Benyahia, B Mabro, M Raphael, JC Gajdos, P Delattre, JY Gray, F
Citation: T. Sharshar et al., Association of herpes simplex virus encephalitis and paraneoplastic encephalitis - A clinico-pathological study, ANN PATHOL, 20(3), 2000, pp. 249-252

Authors: Karmochkine, M Mohamed, AS Piketty, C Ginsburg, C Raguin, G Schneider-Fauveau, V Gutmann, L Kazatchkine, MD Belec, L
Citation: M. Karmochkine et al., The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients, ANTIVIR RES, 47(3), 2000, pp. 179-188

Authors: Belec, L Slaninova, J Lubell, WD
Citation: L. Belec et al., A study of the relationship between biological activity and prolyl amide isomer geometry in oxytocin using 5-tert-butylproline to augment the Cys(6)-Pro(7) amide cis-isomer population, J MED CHEM, 43(8), 2000, pp. 1448-1455
Risultati: 1-25 | 26-45